News
Biophore India Pharmaceuticals Announced That It Developed and Started Manufacturing the ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, 'Biophore India Pharmaceuticals announced that it developed and started manufacturing the key intermediates of Nirmatrelvir, one of the active ingredients of #Paxlovid, the latest anti-#COVID therapy, approved by #US authorities.'
Biophore India Pharmaceuticals announced that it developed and started manufacturing the key intermediates of Nirmatrelvir, one of the active ingredients of #Paxlovid, the latest anti-#COVID therapy, approved by #US authorities. pic.twitter.com/Lav21xvv4Y— IANS Tweets (@ians_india) January 19, 2022
(The above story first appeared on LatestLY on Jan 19, 2022 04:24 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
